# Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

> **NCT06334575** · PHASE4 · RECRUITING · sponsor: **Maria Joyera Rodríguez** · enrollment: 135 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT06334575
- **Lead sponsor:** Maria Joyera Rodríguez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-12
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06334575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06334575, "Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06334575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*